Bosh sahifaNWBO • OTCMKTS
add
Northwest Biotherapeutics Inc
Yopilish kursi
0,25 $
Kunlik diapazon
0,22 $ - 0,26 $
Yillik diapazon
0,17 $ - 0,48 $
Bozor kapitalizatsiyasi
345,05 mln USD
Oʻrtacha hajm
2,15 mln
Narx/foyda
-
Dividend daromadliligi
-
Asosiy maydon
OTCMKTS
Bozor yangiliklari
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 375,00 ming | 32,04% |
Joriy xarajat | 9,34 mln | 15,45% |
Sof foyda | -19,34 mln | -5,63% |
Sof foyda marjasi | -5,16 ming | 20,00% |
Har bir ulushga tushum | — | — |
EBITDA | -16,88 mln | -10,19% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 2,78 mln | 12,15% |
Jami aktivlari | 27,50 mln | -3,72% |
Jami passivlari | 112,34 mln | 36,94% |
Umumiy kapital | -84,84 mln | — |
Tarqatilgan aksiyalar | 1,44 mlrd | — |
Narxi/balansdagi bahosi | -3,57 | — |
Aktivlardan daromad | -159,60% | — |
Kapitaldan daromad | 316,21% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (USD) | mar, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -19,34 mln | -5,63% |
Operatsiyalardan naqd pul | -9,42 mln | 24,09% |
Sarmoyadan naqd pul | -93,00 ming | 61,09% |
Moliyadan naqd pul | 11,73 mln | -2,91% |
Naqd pulning sof oʻzgarishi | 604,00 ming | 71,59% |
Boʻsh pul | -5,65 mln | 0,97% |
Haqida
Northwest Biotherapeutics, Inc. is a development-stage American pharmaceutical company headquartered in Maryland that focuses on developing immunotherapies against different types of cancer. It was founded in 1996 by Alton L. Boynton. Wikipedia
Tashkil etilgan
1-yan, 1998
Sayt
Xodimlar soni
25
